COVID-19 Research Timeline

China reportes a cluster of cases of pneumonia in Wuhan, Hubei Province
(Image credit: NIAID-RML)

The World Health Organization issues Disease Outbreak News – Pneumonia of unknown cause
(Image credit: NIAID)

VIDO initiates vaccine development against the novel coronavirus

VIDO receives permission from the Public Health Agency of Canada to work with SARS-CoV-2
News Release

Clinical samples received from Sunnybrook through the National Microbiology Laboratory

SARS-CoV-2 successfully isolated in our containment level 3 facility

Initiated development of a ferret model of COVID-19

Dr. Falzarano and team awarded ~$1 million from the Canadian Institutes of Health Research
News Release

Immunized ferrets with two COVID-19 vaccine candidates

Prime Minister of Canada announces $23.3 million to support vaccine manufacturing and CL3 operations
News Release

Government of Saskatchewan awards $3.6 million in new funding for COVID-19 vaccine research
News Release

Initiated development of a golden hamster model of COVID-19

Government of Canada awards an additional $23 million to accelerate vaccine development
News Release

Immunized hamsters with our COVID-19 vaccine candidate

Pre-clinical results in ferret model demonstrates COVID-19 vaccine candidate is highly effective
News Release

Canadian universities partner to fight COVID-19 at USask’s VIDO
News Release

Initiated toxicology studies
(Image credit: NIAID-RML)

Received a notice of authorization from Health Canada to initiate a Phase 1 clinical vaccine trial
News Release

First volunteers vaccinated
News Release

Positive Phase 1 results for COVAC-2
News Release

Clinical trials continue
COVID-19 Vaccine Trials